Are We Doing Enough for Childrens Pain? Richard F Howard Great - - PowerPoint PPT Presentation

are we doing enough for children s pain
SMART_READER_LITE
LIVE PREVIEW

Are We Doing Enough for Childrens Pain? Richard F Howard Great - - PowerPoint PPT Presentation

Are We Doing Enough for Childrens Pain? Richard F Howard Great Ormond Street Hospital for Children London UK Acute pain Chronic pain Pain in the neonate Historical context - acute pain Eland JM and Anderson JE 1977


slide-1
SLIDE 1

Are We Doing Enough for Children’s Pain?

Richard F Howard Great Ormond Street Hospital for Children London UK

slide-2
SLIDE 2
  • Acute pain
  • Chronic pain
  • Pain in the neonate
slide-3
SLIDE 3

Historical context

  • acute pain
  • Eland JM and Anderson JE

1977

  • Schechter NL et al

1986

  • Asprey JR

1994

  • Ellis et al

2002

  • CHI / Healthcare Commission

2004

slide-4
SLIDE 4

Postoperative pain after day case surgery

30% ‘unbearable pain’ in first 24hrs

  • Romsing 1996
  • Hamers 2002: 67% remember severe pain in hospital
  • Adenoidectomy: 20% moderate to severe pain
  • Kokki 1997
  • Tonsillectomy: 35-75% severe pain
  • Warnock 1998, Swallow 2003
  • Orchidopexy: 30% moderate to severe
  • Ho 2000
slide-5
SLIDE 5

Acute pain

Problem:

  • available treatments are not being used
  • new treatments (slow to become) or not

available

slide-6
SLIDE 6

Chronic pain

  • Goodman JE, McGrath PJ

1991

  • Perquin CW et al

2000

  • Schanberg LE et al

2003

  • Weydert JA et al

2003

slide-7
SLIDE 7

Chronic pain at GOSH 1998-2003

0% 5% 10% 15% 20% 25% 30% 35% Neuropathic E.B. Misc CPS CRPS

slide-8
SLIDE 8

Chronic pain

  • Very little information about the efficacy
  • f treatments for chronic pain in children
  • Medicines for the treatment of

neuropathic pain all unlicenced for paediatric use

slide-9
SLIDE 9

Pain in the neonate

slide-10
SLIDE 10

Understanding analgesic effects in the neonate

  • Pharmacokinetics
  • Pharmacodyamic changes during development

– receptor distribution – functional sensitivity – Non analgesic effects

  • Additional

– individual variability in analgesic response – genetic variability

slide-11
SLIDE 11

Pain in the neonate

  • history
  • Unable to feel pain due to

underdevelopment of CNS at birth

  • Found to produce substantial pain-

related stress response

  • Increased research interest

x

slide-12
SLIDE 12

the mechanisms of pain are different in infancy Nociception Persistent pain

slide-13
SLIDE 13

Summary of changes in pain processing during postnatal development

  • Nociceptor and sensory neuron function
  • Descending modulation
  • Receptor distribution and function
  • Peripheral and spinal mechanisms of persistent pain
slide-14
SLIDE 14

Long term effects of pain in infancy ?

  • Effect of neonatal circumcision on pain

response during subsequent routine vaccination.

Taddio et al Lancet. 1997;349:599-603.

  • Major surgery within the first three

months of life..

Peters et al Pediatrics 2003; 111:129-135

Normal development is activity dependent

slide-15
SLIDE 15

Pain in the neonate

  • Neurobiology is age dependant
  • Few human studies of efficacy
  • Important concerns about side effects, toxicity

and long term consequences of therapy

slide-16
SLIDE 16

Medicines for children

Children, young people, their parents or carers, and health care professionals in all settings make decisions about medicines based on sound information about risk and benefit. They have access to safe and effective medicines that are prescribed on the basis of the best available evidence.

  • Standard. NSF for Children 2004, DH. UK. Available at www.dh.gov.uk
slide-17
SLIDE 17

Current Best Evidence in Paediatric Acute Pain?

NH&MRC Acute Pain Management Guideline

  • Level I & II

– adult 67% – paediatric 8%

  • Level III & IV

– adult 33% – paediatric 92%

slide-18
SLIDE 18

Clinical questions

Difficulties in paediatric clinical research studies

  • subjective nature of pain
  • lack of acceptable outcome standards
  • inability to self report
  • weaknesses of pain assessment
  • ethical considerations: placebo, consent,

recruitment, design problems

slide-19
SLIDE 19

Efficacy of Paracetamol (Acetaminophen) in Paediatric Studies

– age range – dose – assessment – outcome – comparison / “control” group

Difficult to combine studies as variability in:

slide-20
SLIDE 20

Pain in children What should we be doing to improve pain management in children?

slide-21
SLIDE 21

Evidence Based Paediatric Pain Management

  • laboratory investigation of mechanisms and

developmental changes

  • better designed clinical trials

– consideration of developmental age, mechanism – standardized outcomes; objective assessments – child friendly and appropriate formulations

  • ongoing evaluation of evidence
  • education and training
  • accelerate transition

science → trials → clinical practice

slide-22
SLIDE 22